CareDx's AlloSeq Tx 17 Awarded CE Mark Approval
AlloSeq Tx 17 is the best in class solution for matching transplant donor organs to recipients, utilizing next generation Hybrid Capture technology for HLA testing.
"AlloSeq Tx 17 eliminates PCR disadvantages such as allele drop out and provides a simple workflow that could be easily implemented in Histocompatibility & Immunogenetics laboratories. Generation of reliable data and ability to extend the typing to additional non-classical HLA loci will provide better care for patients," said Milena Ivanova-Shivarova, Lab Manager,
For more information, please visit: www.CareDx.com.
Chief Marketing Officer,
Source: CareDx, Inc.